| CONFERENCE PARTICIPANTS
|
From the UK
Almac Diagnostics
AstraZeneca, UK
Axis-Shield Diagnostics
BioPartner.co.uk
Compandia Ltd
Datatrial
GSK
High Force Research Ltd
INC Research
Integrated Medicines
Lab21 Healthcare
Medidata
Nextgen Sciences
Oxford Gene Technology
Pharmalicensing
Premier Research
Price Waterhouse Coopers
Qiagen UK Ltd. (DxS)
Scottish Development International
Source Bioscience
TEVA Pharmaceutical Industries Ltd
The Clinical Trial Company
The Technology Partnership plc
Theradex (Europe) Ltd
University of Portsmouth
|
From the Nordics
2cureX
aCROnordic a/s
Biopeople
Biotec Pharmacon ASA
CMC Contrast AB
Copenhagen Capacity
CytoTrack ApS
Dako Denmark A/S
DanDrit Biotech A/S
Diagenic ASA
Embassy of Canada in Sweden
Exiqon A/S
FluimediX
Genomic Expression
i3 Research
Innovation Team
Insightasy AB
KaroBio
Kuros ApS
Medical Prognosis Institute
MicroMorph AB
Novo Nordisk
Olink
Oncos Therapeutics
Pipeline Biotech
Plexpress Oy
Scandinavian Life Science Invest AB
SEED Capital Denmark
SentoClone
Smerud Medical Research
TECTRA
TFS Trial Form Support AB
TopoTarget A/S
University of Copenhagen
University of Iceland
Wiborg ApS
|
To find out more about the Conference, please contact Project Manager, Christina Bergstrand, at +46-86713065 or cb@britishembassy.se
|
|